ImageneBio (IMA) Earnings Date & Reports

ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IMA is expected to report earnings to fall 24.21% to -72 cents per share on November 11

Q3'26

Est.

$-0.72

Q1'26

Missed

by $0.75

Q4'25

Missed

by $0.11

Q2'25

Missed

by $0.55

The last earnings report on May 07 showed earnings per share of -94 cents, missing the estimate of -20 cents. With 9.40K shares outstanding, the current market capitalization sits at 62.55M.

View a ticker or compare two or three

IMA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days